BioMarin receives FDA nod for its would-be blockbuster
May 25, 2018Medical Communications, Sales and Marketing BioMarin, biotech, drugs, pharma, pharmaceutical
BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …
AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer
May 25, 2018Medical Communications, Research and Development AstraZeneca, Imfinzi, NSCLC, lung cancer, pharma
AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi …
Breast cancer screening scandal potentially involves even more women
May 25, 2018Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical
The news broke at the start of the month that a number of women who should have been invited to …
Prothena guts workforce by more than half, after trial failure
May 25, 2018Medical Communications Neil Woodford, Prothena, Roche, biotech, drugs, pharma, pharmaceutical
Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …
FDA cracks down on benzocaine teething products
May 24, 2018Sales and Marketing FDA, benzocaine, pharma, teething products
The FDA has put its foot down on over-the-counter teething products for infants and children which contain benzocaine, a pain …
John Crowley speaks on drug development and the FDA
May 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical
Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.
Astellas begins major restructure, as 600 jobs slashed
May 24, 2018Medical Communications Astellas, biotech, drugs, pharma, pharmaceutical
Astellas, under the direction of new CEO, Kenji Yasukawa, has unveiled a major new restructure, ahead of a difficult looking …
Novartis’ Sandoz scores EU approval for Remicade biosimilar
May 24, 2018Sales and Marketing EU, Europe, Novartis, Remicade, Sandoz, Zessly, pharma
The European Commission has given its approval to Sandoz, Novartis’ generics and biosimilars unit, for its biosimilar version of Janssen’s …
Report calls for tax rises to fund ailing NHS
May 24, 2018Medical Communications IFS, NHS, UK government, biotech, drugs, pharma, pharmaceutical
A report published by the Institute for Fiscal Studies (IFS) has stressed that UK funding into the NHS needs to …
MSD’s Keytruda scores impressive first-line lung cancer data
May 24, 2018Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical
MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its …
Vifor Fresenius snap up rights to Cara’s itch therapy
May 23, 2018Research and Development, Sales and Marketing Cara Therapeutics, Vifor Fresenius, biotech, drugs, pharma, pharmaceutical
The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …
Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer
May 23, 2018Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer
Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …
World heading towards 25% of total population being obese
May 23, 2018Research and Development WHO, biotech, drugs, obesity, pharma, pharmaceutical
The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …
FDA reprimands suppliers of opioid substitute kratom products
May 23, 2018Research and Development, Sales and Marketing FDA, kratom, opioid crisis, opioids, pharma
The ongoing opioid epidemic in the US has seen the rise of the sale and use of kratom (mitragyna speciose), …
Takeda begins to shore up finances with $280m divestment
May 23, 2018Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical
Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …
India, Sweden and The Netherlands form HIV/AIDS research partnership
May 22, 2018Manufacturing and Production, Research and Development AIDS, HIV, India, Sweden, The Netherlands, pharma
A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing …
NHS Trust harnesses AI to speed up treatment
May 22, 2018Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical
The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …
The cause of the most common form of childhood cancer found
May 22, 2018Manufacturing and Production, Research and Development biotech, drugs, leukaemia, pharma, pharmaceutical
Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …
ViiV’s two-drug regimen gets EU approval for HIV-1
May 22, 2018Manufacturing and Production, Sales and Marketing EMA, EU, Europe, HIV, Juluca, ViiV Healthcare, pharma
ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …
Nabriva closes in on bringing new class of antibiotic to market
May 22, 2018Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical
Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …
